An elevated amniotic fluid prostaglandin F 2α concentration is associated with intra-amniotic inflammation/infection, and clinical and histologic chorioamnionitis, as well as impending preterm delivery in patients with preterm labor and intact membranes
- 15 December 2015
- journal article
- research article
- Published by Taylor & Francis in The Journal of Maternal-Fetal & Neonatal Medicine
- Vol. 29 (16) , 2563-2572
Abstract
Objective: To determine whether an elevated amniotic fluid concentration of prostaglandin F2α (PGF2α) is associated with intra-amniotic inflammation/infection and adverse pregnancy outcomes in patients with preterm labor and intact membranes. Materials and methods: The retrospective cohort study included 132 patients who had singleton pregnancies with preterm labor (< 35 weeks of gestation) and intact membranes. Amniotic fluid was cultured for aerobic and anaerobic bacteria as well as for genital mycoplasmas. Intra-amniotic inflammation was defined by an elevated amniotic fluid matrix metalloproteinase-8 (MMP-8) concentration (>23 ng/mL). PGF2α was measured with a sensitive and specific immunoassay. The amniotic fluid PGF2α concentration was considered elevated when it was above the 95th percentile among pregnant women at 15–36 weeks of gestation who were not in labor (≥170 pg/mL). Results: (1) The prevalence of an elevated amniotic fluid PGF2α concentration was 40.2% (53/132) in patients with preterm labor and intact membranes; (2) patients with an elevated amniotic fluid PGF2α concentration had a significantly higher rate of positive amniotic fluid culture [19% (10/53) versus 5% (4/79); p = 0.019], intra-amniotic inflammation/infection [49% (26/53) versus 20% (16/79); p = 0.001], spontaneous preterm delivery, clinical and histologic chorioamnionitis, and funisitis, as well as a higher median amniotic fluid MMP-8 concentration and amniotic fluid white blood cell count and a shorter amniocentesis-to-delivery interval than those without an elevated concentration of amniotic fluid PGF2α (p < 0.05 for each); and (3) an elevated amniotic fluid PGF2α concentration was associated with a shorter amniocentesis-to-delivery interval after adjustment for the presence of intra-amniotic inflammation/infection [hazard ratio 2.1, 95% confidence interval (CI) 1.4–3.1; p = 0.001]. Conclusion: The concentration of PGF2α was elevated in the amniotic fluid of 40.2% of patients with preterm labor and intact membranes and is an independent risk factor for intra-amniotic inflammation/infection, impending preterm delivery, chorioamnionitis, and funisitis.Keywords
This publication has 224 references indexed in Scilit:
- Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010The Lancet, 2012
- Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000The Lancet, 2012
- Long-term neurodevelopmental outcomes after intrauterine and neonatal insults: a systematic reviewThe Lancet, 2012
- Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double‐blind, placebo‐controlled trialUltrasound in Obstetrics & Gynecology, 2011
- The “Great Obstetrical Syndromes” are associated with disorders of deep placentationAmerican Journal of Obstetrics and Gynecology, 2011
- Cervical remodeling during pregnancy and parturitionTrends in Endocrinology & Metabolism, 2010
- Diagnosis and Management of Clinical ChorioamnionitisClinics in Perinatology, 2010
- Relationships Between Mechanical Properties and Extracellular Matrix Constituents of the Cervical Stroma During PregnancySeminars in Perinatology, 2009
- Integration of endocrine and mechanical signals in the regulation of myometrial functions during pregnancy and labourEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2009
- Epidemiology and causes of preterm birthThe Lancet, 2008